Bio-thera Solutions, Ltd. Class ASSE: 688177

"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for Supplementary Application for Bevacizumab Injection (POBEVCY)

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for Supplementary Application for Bevacizumab Injection (POBEVCY)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Bio-thera Solutions, Ltd. Class A

All Bio-thera Solutions, Ltd. Class A news releases